LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
13.75
+0.21 (1.55%)
At close: Jun 27, 2025, 4:00 PM
13.48
-0.27 (-1.96%)
After-hours: Jun 27, 2025, 7:58 PM EDT

LifeMD Statistics

Total Valuation

LifeMD has a market cap or net worth of $624.90 million. The enterprise value is $615.61 million.

Market Cap 624.90M
Enterprise Value 615.61M

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, after market close.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

LifeMD has 45.45 million shares outstanding. The number of shares has increased by 17.81% in one year.

Current Share Class 45.45M
Shares Outstanding 45.45M
Shares Change (YoY) +17.81%
Shares Change (QoQ) +8.00%
Owned by Insiders (%) 14.84%
Owned by Institutions (%) 37.04%
Float 37.00M

Valuation Ratios

PE Ratio n/a
Forward PE 141.03
PS Ratio 2.48
Forward PS 2.18
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio 44.82
P/OCF Ratio 40.63
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.63
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 44.16

Financial Position

The company has a current ratio of 0.82

Current Ratio 0.82
Quick Ratio 0.73
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF 1.80
Interest Coverage -3.19

Financial Efficiency

Return on equity (ROE) is -2,243.07% and return on invested capital (ROIC) is -20.23%.

Return on Equity (ROE) -2,243.07%
Return on Assets (ROA) -6.88%
Return on Invested Capital (ROIC) -20.23%
Return on Capital Employed (ROCE) -58.45%
Revenue Per Employee $762,239
Profits Per Employee -$45,065
Employee Count 307
Asset Turnover 3.46
Inventory Turnover 10.53

Taxes

In the past 12 months, LifeMD has paid $402,000 in taxes.

Income Tax 402,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +98.13% in the last 52 weeks. The beta is 2.43, so LifeMD's price volatility has been higher than the market average.

Beta (5Y) 2.43
52-Week Price Change +98.13%
50-Day Moving Average 10.30
200-Day Moving Average 6.63
Relative Strength Index (RSI) 61.04
Average Volume (20 Days) 2,135,170

Short Selling Information

The latest short interest is 3.58 million, so 7.87% of the outstanding shares have been sold short.

Short Interest 3.58M
Short Previous Month 3.51M
Short % of Shares Out 7.87%
Short % of Float 9.67%
Short Ratio (days to cover) 1.88

Income Statement

In the last 12 months, LifeMD had revenue of $234.01 million and -$13.83 million in losses. Loss per share was -$0.33.

Revenue 234.01M
Gross Profit 205.90M
Operating Income -7.43M
Pretax Income -23.07M
Net Income -13.83M
EBITDA -5.86M
EBIT -7.43M
Loss Per Share -$0.33
Full Income Statement

Balance Sheet

The company has $34.39 million in cash and $25.10 million in debt, giving a net cash position of $9.29 million or $0.20 per share.

Cash & Cash Equivalents 34.39M
Total Debt 25.10M
Net Cash 9.29M
Net Cash Per Share $0.20
Equity (Book Value) -392,754
Book Value Per Share -0.05
Working Capital -10.93M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $15.38 million and capital expenditures -$1.44 million, giving a free cash flow of $13.94 million.

Operating Cash Flow 15.38M
Capital Expenditures -1.44M
Free Cash Flow 13.94M
FCF Per Share $0.31
Full Cash Flow Statement

Margins

Gross margin is 87.99%, with operating and profit margins of -3.18% and -4.58%.

Gross Margin 87.99%
Operating Margin -3.18%
Pretax Margin -4.17%
Profit Margin -4.58%
EBITDA Margin -2.51%
EBIT Margin -3.18%
FCF Margin 5.96%

Dividends & Yields

LifeMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.81%
Shareholder Yield -17.81%
Earnings Yield -2.21%
FCF Yield 2.23%

Analyst Forecast

The average price target for LifeMD is $11.00, which is -20.00% lower than the current price. The consensus rating is "Strong Buy".

Price Target $11.00
Price Target Difference -20.00%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 14, 2020. It was a reverse split with a ratio of 0.2:1.

Last Split Date Oct 14, 2020
Split Type Reverse
Split Ratio 0.2:1

Scores

LifeMD has an Altman Z-Score of 0.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.41
Piotroski F-Score 4